However the biological consequence and relevance of lowered Erk activity upon TCR reactivation leading to lowered FasL protein and reduced caspase activity in Th17 cells suggest direct proof of principle for their AICD resistance and higher incidence in inflammatory diseases including psoriasis, RA, inflammatory bowel disease and multiple sclerosis [36–39]. The gene discussed is MAPK1; the disease is multiple sclerosis.